Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
7.810
+0.460 (+6.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
Nvidia Bolsters AI Leadership with Investment in Arm Holdings, Eyes Future Growth in Semiconductor Industry
February 15, 2024
Nvidia's investment portfolio includes stakes in Arm Holdings, SoundHound AI, and Recursion Pharmaceuticals. Despite failed acquisition, Arm's market valuation has soared to $130 billion. Significant...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia Discloses Stakes In Arm, SoundHound AI, Nano-X And More
February 14, 2024
The AI chip leader revealed investments in its first-ever 13F SEC filing late Wednesday.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Regulatory Compliance
Exposures
Artificial Intelligence
Legal
Regulatory
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
February 08, 2024
These two platform biotechs could revolutionize the field of biologically based products.
Via
The Motley Fool
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
February 07, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
A Glimpse Into The Expert Outlook On Recursion Pharmaceuticals Through 4 Analysts
January 17, 2024
Via
Benzinga
What's Going On With Recursion Pharmaceuticals Stock?
January 09, 2024
Via
Benzinga
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
February 07, 2024
They aren't all long shots, but they're all innovative.
Via
The Motley Fool
2 Under-the-Radar Stocks With Incredible Upside Potential
January 28, 2024
It's also important to consider their downsides.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week
January 25, 2024
The widely followed growth stock investor is adding to some of her holdings this week.
Via
The Motley Fool
Altitude Lab Startups Raise Over $120M in Capital
January 24, 2024
Launches Fellowship Grant Opportunity for Early Career Entrepreneurs
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Peering Into Recursion Pharmaceuticals's Recent Short Interest
January 01, 2024
Via
Benzinga
Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares
January 17, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
Via
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
January 15, 2024
These companies are still in the early innings of their growth potential.
Via
The Motley Fool
Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights
January 13, 2024
Nvidia provides artificial intelligence solutions for various markets, including the healthcare and automotive industries.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
These companies could stand out thanks to game-changing technology.
Via
The Motley Fool
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
January 09, 2024
Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.
Via
InvestorPlace
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
January 09, 2024
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024
Recursion and NVIDIA will host an invite-only event on Wednesday, January 10, where Recursion will provide live demonstrations of LOWE, its new LLM-based software that can perform complex drug...
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
January 04, 2024
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024
January 03, 2024
The widely followed aggressive growth investor is adding to some of her holdings as she kicks off the new year.
Via
The Motley Fool
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
January 02, 2024
Via
Benzinga
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.
Via
InvestorPlace
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
Via
Talk Markets
Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher
December 26, 2023
On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before.
Via
Investor's Business Daily
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
December 20, 2023
Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets.
From
Recursion Pharmaceuticals
Via
GlobeNewswire
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Via
InvestorPlace
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.